Dr. Craig Puckett is a Partner and leader of the Chemical Group section of the Life Sciences Group at Pearl Cohen’s New York office.
Craig has substantial experience counselling clients on developing their worldwide patent portfolio in order to achieve their business goals. Craig successfully defended patents at the USPTO and European Patent Office oppositions. Craig’s extensive experience includes counselling on the freedom to operate, patentability, and invalidity opinions; ANDA paragraph IV certifications; due diligence analysis of patent portfolios; and patent procurement, both domestic and foreign. Craig’s domestic patent experience includes arguing cases before the Board of Patent Appeals and Interferences as well as interviewing cases at the US Patent and Trademark Office (USPTO) and drafting appeal briefs. His international patent procurement experience includes prosecuting patents in Europe, Germany, United Kingdom, Italy, Australia, CN, Taiwan, Japan, Korea, Mexico, Peru, Argentina, and Chile.
Craig holds a doctoral degree in organic chemistry and focuses his practice on a variety of intellectual property law issues in the pharmaceutical and diversified chemical fields. His pharmaceutical experience extends to products from A to Z: generic versions of armodafinil, candesartan, leflunomide, ondansetron, and zolpidem, among many others. Craig has substantial expertise procuring patents directed to pharmaceutical compounds, medical formulations, methods of drug administration, methods of treating medical conditions, biotechnology (peptides and small molecules), medical devices, food chemistry, and diversified chemicals such as polymers, petroleum refinement, and catalysts. Craig has drafted over 150 domestic patent applications and over 60 opinions for his clients.
Prior to joining Pearl Cohen, Craig worked for the intellectual property boutiques of Pennie & Edmonds, LLP and Kenyon & Kenyon LLP. During his third year in law school, Craig served as a judicial intern with the Honorable Paul Michel of the Court of Appeals for the Federal Circuit. Upon his return to law school, Craig was the Director of the Franklin Pierce Innovation Clinic, which counselled inventors and start-up companies in their patent portfolio development.